Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R–CHOP chemotherapy

Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R–CHOP chemotherapy

Abstract Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin’s lymphoma, for which cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab(R–CHOP) is one of the standard regimens. Given that R–CHOP is highly emetogenic, chemotherapy-induced nausea and vomit...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Kunye Kwak, Yong Park, Byung Soo Kim, Ka-Won Kang
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Nature Portfolio 2024-05-01
Seri Bilgileri:Scientific Reports
Konular:
Chemotherapy induced nausea and vomiting
Netupitant
Palonosetron
Diffuse large B cell lymphoma
Chemotherapy
Antiemetics
Online Erişim:https://doi.org/10.1038/s41598-024-62057-4

Internet

https://doi.org/10.1038/s41598-024-62057-4

Benzer Materyaller